ADPT
Price
$8.27
Change
-$0.06 (-0.72%)
Updated
Feb 21 closing price
Capitalization
1.22B
67 days until earnings call
ARRY
Price
$6.59
Change
-$0.31 (-4.49%)
Updated
Feb 21 closing price
Capitalization
2.22B
5 days until earnings call
Ad is loading...

ADPT vs ARRY

Header iconADPT vs ARRY Comparison
Open Charts ADPT vs ARRYBanner chart's image
Adaptive Biotechnologies
Price$8.27
Change-$0.06 (-0.72%)
Volume$1.43M
Capitalization1.22B
Array Technologies
Price$6.59
Change-$0.31 (-4.49%)
Volume$3.37M
Capitalization2.22B
ADPT vs ARRY Comparison Chart
Loading...
ADPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ARRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADPT vs. ARRY commentary
Feb 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADPT is a Hold and ARRY is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 22, 2025
Stock price -- (ADPT: $8.33)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADPT’s FA Score shows that 0 FA rating(s) are green while.

  • ADPT’s FA Score: 0 green, 5 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADPT’s TA Score shows that 3 TA indicator(s) are bullish while ARRY’s TA Score has 4 bullish TA indicator(s).

  • ADPT’s TA Score: 3 bullish, 4 bearish.
  • ARRY’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, ARRY is a better buy in the short-term than ADPT.

Price Growth

ADPT (@Biotechnology) experienced а -2.23% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.57%. For the same industry, the average monthly price growth was +3.87%, and the average quarterly price growth was +3.11%.

Reported Earning Dates

ADPT is expected to report earnings on Apr 30, 2025.

Industries' Descriptions

@Biotechnology (+4.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARRY($2.22B) has a higher market cap than ADPT($1.22B). ADPT YTD gains are higher at: 38.949 vs. ARRY (14.238). ARRY has higher annual earnings (EBITDA): 276M vs. ADPT (-163.5M). ARRY (249M) and ADPT (243M) have equal amount of cash in the bank . ADPT has less debt than ARRY: ADPT (91.8M) vs ARRY (730M). ARRY has higher revenues than ADPT: ARRY (1.58B) vs ADPT (177M).
ADPTARRYADPT / ARRY
Capitalization1.22B2.22B55%
EBITDA-163.5M276M-59%
Gain YTD38.94914.238274%
P/E RatioN/A26.23-
Revenue177M1.58B11%
Total Cash243M249M98%
Total Debt91.8M730M13%
FUNDAMENTALS RATINGS
ARRY: Fundamental Ratings
ARRY
OUTLOOK RATING
1..100
58
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
31
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ADPTARRY
RSI
ODDS (%)
Bearish Trend 3 days ago
87%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
83%
Momentum
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
89%
MACD
ODDS (%)
Bullish Trend 3 days ago
89%
Bearish Trend 3 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
85%
Advances
ODDS (%)
N/A
Bullish Trend 5 days ago
80%
Declines
ODDS (%)
Bearish Trend 5 days ago
86%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
78%
View a ticker or compare two or three
Ad is loading...
ADPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ARRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RLIEX17.230.06
+0.35%
Lazard International Equity R6
JHTRX19.91N/A
N/A
JPMorgan Hedged Equity 3 R6
BRSBX14.29N/A
N/A
MFS Blended Research Small Cap Eq B
HSUCX34.13N/A
N/A
Rational Dynamic Brands C
OIEPX24.91N/A
N/A
JPMorgan Equity Income R3